Comprehensive Medical Screening: Clinicians should evaluate for: Thyroid nodules or goiter : Baseline neck examination and review of recent thyroid ultrasound if clinically indicated Personal or family history of thyroid cancer : Particularly medullary thyroid carcinoma Comorbid conditions : Type 2 diabetes, cardiovascular disease, pancreatitis history Gastrointestinal disorders : Severe gastroparesis (potential contraindication) Renal function : Use caution in patients at risk for volume depletion/renal impairment Psychiatric conditions : Depression, eating disorders Pregnancy status : These medications are not recommended during pregnancy and should be discontinued when pregnancy is recognized Laboratory Assessment: Baseline testing should include: TSH and free T4 Comprehensive metabolic panel (renal and hepatic function) Lipid panel Hemoglobin A1c (if diabetic or prediabetic) Routine calcitonin screening or thyroid ultrasound is not recommended solely for GLP-1 therapy initiation

The most common cause of Cushing's syndrome is exogenous glucocorticoid use
An enzyme called g lutathione peroxidase triggers the conversion of reduced glutathione to oxidized glutathione, a free radical itself
For the comparison of the semaglutide OW cohort versus the SGLT2i cohort, 439 and 1089 patients, were identified respectively
Drug Interactions and Limitations of Use Tirzepatide slows gastric emptying and may affect the absorption of oral medications
How Biosimilar Companies Are Responding: Diversification Into Bio-Better Development Major biosimilar developers including Sandoz, Samsung Bioepis, and Celltrion have been adding next-generation biologic programs alongside their core biosimilar pipelines